Stock CPMD CANNAPHARMARX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company CannaPharmaRX, Inc.

Equities

CPMD

US13765D1090

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 20:27:10 17/06/2024 BST 		5-day change 1st Jan Change
0.0125 USD -14.38% Intraday chart for CannaPharmaRX, Inc. 0.00% +635.29%
06-25 CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06-04 CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with ICAN Green S.A. de C.V to Create Distribution Network in the Latin Americas CI

Business Summary

CannaPharmaRx, Inc. is focused on the acquisition and development of state-of-the-art cannabis growing facilities in Canada. The Company is engaged in producing customizable medical cannabis and craft products. Its business strategy is to produce a high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. The Company is focused on operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis. The Company also offers a range of services to assist with cannabis inventory management.

Number of employees: 21

Managers

Managers TitleAgeSince
Dean Medwid CEO
 Chief Executive Officer - 31/05/23
Dominick Colvin CEO
 Chief Executive Officer 55 31/12/16
Oliver Foeste DFI
 Director of Finance/CFO 48 12/10/23
John Cassels AUD
 Comptroller/Controller/Auditor 75 22/04/19

Members of the board

Members of the board TitleAgeSince
Rick Orman BRD
 Director/Board Member 74 22/04/19
Dominick Colvin CEO
 Chief Executive Officer 55 31/12/16
Anthony Panek BRD
 Director/Board Member 39 24/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 2,455,000 0 0 98.96 %
Stock B 1 668,732,166 661,875,680 ( 98.97 %) 6,230,761 ( 0.9317 %)
Stock C 0 84,416 0 0

Shareholders

NameEquities%Valuation
Rick Orman
0.0944 %
625,725 0.0944 % 8 760 $

Company contact information

CannaPharmaRx, Inc.

888 3rd Street South West Suite 3600

T2P 5C5, Calgary

+

http://www.cannapharmarx.com
address CannaPharmaRX, Inc.(CPMD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CANNAPHARMARX, INC. Stock CannaPharmaRX, Inc.
+635.29% 8.2M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.61% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.56% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.62% 333B
ABBVIE INC. Stock AbbVie Inc.
+10.44% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.58% 225B
NOVARTIS AG Stock Novartis AG
+12.87% 218B
AMGEN INC. Stock Amgen Inc.
+8.61% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CPMD Stock
  4. Company CannaPharmaRX, Inc.